Status:
COMPLETED
Treatment of Postviral Olfactory Dysfunction
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
Region Skane
Conditions:
Hyposmia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
A decreased sense of smell (hyposmia) is often caused by viral infections, such as COVID-19. Today, the only recommended treatment for hyposmia is olfactory training, a time consuming method with limi...
Eligibility Criteria
Inclusion
- 18 - 65 years old
- Physically and cognitively capable of participating in the study
- Having appropriate olfactory screening test scores (hyposmic)
Exclusion
- Anosmics
- Individuals with other diagnoses that could affect the study results
Key Trial Info
Start Date :
October 17 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2025
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT06142565
Start Date
October 17 2023
End Date
July 1 2025
Last Update
September 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Karolinska Institutet
Solna, Stockholm County, Sweden, 17177